Skip to content
Wednesday 26 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,878.12
-0.07%
DAX
26,285.96
+0.08%
CAC 40
8,462.39
+0.27%
STOXX 50
6,470.74
+0.23%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE

Businesswire

  • IGI Announces Quarterly Ordinary Common Share Dividend

    December 3, 2025

    International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that its Board of Directors has declared an ordinary common share dividend of $0.05 per share for the period July 1, 2025 – September 30, 2025. The dividend is payable on December 31, 2025 to shareholders of record at the close of [...]

  • LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting

    December 3, 2025

    Eight scientific posters demonstrate significant seizure reduction and improved outcomes with VNS Therapy in patients with Drug-Resistant Epilepsy

  • Perma-Pipe International Holdings, Inc. Secures $52 Million in Third-Quarter Awards, Expands Global Reach With U.S. Data Centers and Saudi Aramco Projects

    December 3, 2025

    Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) today announced that it secured $52 million in project awards during the third quarter of 2025, including $30 million previously announced in September. The additional $22 million in new awards includes major data center infrastructure projects in the United States and Saudi Aramco–related projects to be executed from the [...]

  • ILiAD Biotechnologies Announces Lancet Microbe Publication of BPZE1 Phase 2b Clinical Results in Human Challenge Model

    December 3, 2025

    Study Highlights First-ever Demonstration of Protection Against B. pertussis Colonization in Humans

  • Options Appoints Former Exergy / ICE Sales Director, Bob Coletti as Sales Director Strategic Accounts

    December 3, 2025

    Options Technology, a leading provider of high-performance trading infrastructure and market data solutions, today announced the appointment of Bob Coletti as Sales Director, Strategic Accounts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251203430077/en/ With a career spanning senior commercial roles across the financial technology ecosystem, Bob has built a reputation for cultivating [...]

  • LumRisk Announces Strategic Reset and USD 5 Million Capital Commitment to Accelerate Its Transformation Toward an AI-Driven QIS and Multi-Asset Platform

    December 3, 2025

    LumRisk today announced a major milestone in its evolution, with the approval and implementation of a comprehensive corporate reset. This includes the restructuring of legacy obligations and the reinforcement of the company’s balance sheet. These measures establish a strong foundation for a new phase of accelerated global growth across LumRisk’s core domains: Quantitative Investment Strategies [...]

  • TITAN Honored With ESG Transparency Award 2025 for Excellence in Disclosure

    December 3, 2025

    TITAN Group (Brussels:TITC) has been recognized for setting a benchmark in transparent ESG reporting, earning the prestigious ESG Transparency Award 2025 from the EUPD Group, Europe’s leading market research institute. This marks the second consecutive year TITAN has received this distinction, with its score rising from 89% to 95%, reinforcing its reputation for openness, accountability, [...]

  • Taiho Oncology Europe announces the launch of Lytgobi®▼ (futibatinib) in the United Kingdom for eligible adult patients with a previously treated subtype of locally advanced or metastatic cholangiocarcinoma1

    December 3, 2025

    Lytgobi (futibatinib) marks the first medicine launched by Taiho Oncology Europe in the UK2

  • From Tickets to Takeoff: Gig-Tripping Made Seamless with viagogo and Booking.com

    December 3, 2025

    viagogo, the leading global secondary ticketing marketplace, today announced a new partnership with Booking.com, one of the world’s largest travel platforms, to make event-going even more seamless. Through the industry-first partnership, fans purchasing tickets on viagogo can now easily add hotels, flights, rental cars, attractions, and more through Booking.com – turning a bucket list gig [...]

  • Coremont Secures $40M Strategic Investment from Funds Managed by Blue Owl to Accelerate Innovation in Portfolio Analytics

    December 3, 2025

    Coremont, a leading provider of real-time, multi-asset class portfolio management software and analytics, today announced a $40 million strategic growth investment from funds managed by Blue Owl Capital (NYSE: OWL), a leading asset manager with $295 billion in assets under management. The investment recognizes Coremont’s position as a critical infrastructure partner to asset managers, hedge [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 201
  • Page 202
  • Page 203
  • Page 204
  • Page 205
  • …
  • Page 228
  • Next

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Andy Burnham hints at tax rises in Autumn Budget

  • Budget 2026: Which taxes will Burnham and Healey hike?

  • Burnham shelves Thames Water administration plans over costs

  • Economists urge Bank of England to halt bond sales as borrowing costs climb

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook